Multi-omics approaches for drug-response characterization in primary biliary cholangitis and autoimmune hepatitis variant syndrome
Abstract Background Primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH) variant syndrome (VS) exhibit a complex overlap of AIH features with PBC, leading to poorer prognoses than those with PBC or AIH alone. The biomarkers associated with drug response and potential molecular mechanisms...
Main Authors: | Fan Yang, Leyu Zhou, Yi Shen, Xianglin Wang, Xiaoli Fan, Li Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-024-05029-6 |
Similar Items
-
Evaluation of Aflatoxin M1 Effects on the Metabolomic and Cytokinomic Profiling of a Hepatoblastoma Cell Line
by: Silvia Marchese, et al.
Published: (2018-10-01) -
Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis – a case series
by: Mirjam Kolev, et al.
Published: (2023-01-01) -
Autoimmune hepatitis and primary biliary cholangitis overlap syndrome after COVID-19
by: Marlone Cunha-Silva, et al.
Published: (2023-03-01) -
Multi-omics approaches for drug-response characterization in primary biliary cholangitis and autoimmune hepatitis variant syndrome
by: Yang, F, et al.
Published: (2024) -
Overlap syndrome of autoimmune hepatitis and primary biliary cholangitis complicated with atypical hepatocellular carcinoma: a case report
by: Teodora Surdea-Blaga, et al.
Published: (2023-07-01)